Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Service

7.1.  Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Service Type, 2020-2030

7.1.1.    In House

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Contract Outsourcing

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Synthesis Type

8.1.  Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Synthesis Type, 2020-2030

8.1.1.    Chemical-based API

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Biological API

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    HPAPI

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Product Type

9.1.  Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Product Type, 2020-2030

9.1.1.    Antiparasitic

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Anti-infectives

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    NSAIDs

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Vaccines

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Biologics

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Others

9.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Service (2016-2030)

10.1.2.  Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.1.3.  Market Revenue and Forecast, By Product Type (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Service (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Service (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Service (2016-2030)

10.2.2.  Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.2.3.  Market Revenue and Forecast, By Product Type (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Service (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Service (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Service (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Service (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Service (2016-2030)

10.3.2.  Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.3.3.  Market Revenue and Forecast, By Product Type (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Service (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Service (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Service (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Service (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Service (2016-2030)

10.4.2.  Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.4.3.  Market Revenue and Forecast, By Product Type (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Service (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Service (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Service (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Service (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Service (2016-2030)

10.5.2.  Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.5.3.  Market Revenue and Forecast, By Product Type (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Service (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Product Type (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Service (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Synthesis Type (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Product Type (2016-2030)

Chapter 11.  Company Profiles

11.1.              Alivira Animal Health Ltd.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Excel Industries Ltd.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Ofichem Group

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Menadiona

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Afton Pharma.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Jiangsu Lingyun Pharmaceutical Co., Ltd.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              SUANFARMA

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              NGL Fine-Chem Ltd.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           FIS - Fabbrica Italiana Sintetici S.p.A

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms